Department of Health. Report of the working group to examine workloads in genitourinary medicine clinics. London: Department of Health, 1988.
2.
World Health Organization. Consensus statement from consultation on sexually transmitted diseases as a risk factor for HIV transmission. WHO/GPA/INF/ /891, 1989.
3.
PiotPLagaM.Genital ulcers, other sexually transmitted diseases and the sexual transmission of HIV. Br Med J1989;298:623–4.
4.
RogersJSAdlerMW.Role and training of nurses working in departments of genitourinary medicine in England and Wales. Genitourin Med1987;63:112–6.
5.
BoonMEAlons-van-KordelaarJRietveld-ScheffersP.Consequences of the introduction of combined spatula and cytobrush sampling for cervical cytology: Improvements in smear quality and detection rate. Acta Cytol1986;29:264–71.
6.
ByrneMARobinsonD TaylorAndersonMACMasonPHarrisJRW.Value of colposcopy in sexually transmitted disease clinics based on first year's experience. Genitourin Med1989;65:42–5.
7.
OrielJD.Sex and cervical cancer. Genitourin Med1988;64:81–9.
8.
StaflA.Cervicography: A new method for cervical cancer detection. Am J Obstet Gynecol1981;139:815–21.
9.
SpitzerMKrumholzBAChernysAESeltzerVLightmanAR.Comparative utility of repeat Papanicolaou smears, cervicography and colposcopy in the evaluation of atypical Papanicolaou smears. Obstet Gynecol1987;69:731–5.
10.
von KroghGSyrjanenSMSyrjanenKJ.Advantage of human papilloma virus typing in the clinical evaluation of genitoanal warts. J Am Acad Dermatol1988;18:495–503.
11.
TidyJAParryGCNWardPColemanDVPetoJMalcolmADBFarrellPJ.High rate of human papilloma virus type 16 infection in cytologically normal cervices. Lancet1989;i:434.
12.
TidyJAVousdenKHFarrellPJ.Relation between infection with a sub type of HPV 16 and cervical neoplasia. Lancet1989;i:1225–7.
13.
SingerAMcCanceD.The wart virus and genital neoplasia; a casual or causal association. Br J Obstet Gynaecol1985;92:1083–5.
14.
HowleyPM.On human papillomaviruses. N Engl J Med1986;315:1089–90.
15.
SteinBS.Laser treatment of condyloma accuminata. J Urol1986;136:593–4.
16.
EdwardsARamA AtmaThinRN.Podophylotoxin 0.5% v podophyllin 20% to treat penile warts. Genitourin Med1988;64:263–5.
17.
BeutnerKRConantMAFriedman-KienAEIllemanMArtmanNNThistedRAKingDH.Patient-applied podofilox for treatment of genital warts. Lancet1989;i:831–4.
18.
GabrielGThinRN.Treatment of anogenital warts. Comparison of trichloracetic acid and podophyllin versus podophyllin alone. Br J Vener Dis1983;59:124–6.
19.
ThinRN.Management of genital herpes simplex infections. Am J Med1988;85(Suppl 2A):3–6.
20.
HirschMS.The rocky road to effective treatment of human immunodeficiency virus (HIV) infection. Ann Intern Med1989;110:1–3.
21.
BoslegoJWTramontECTakafujiETDiniegaBMMitchellBSSmallJWKhanWNStefnDC.Effect of spectinomycin use on prevalence of spectinomycin-resistant and of penicillinase producing Neisseria gonorrhoeae. N Engl J Med1987;317:272–8.
22.
Van der WilligenVan der HoekJCSWagenvoortJHTComparative double blind study of 200 and 400 mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhoea in males. Antimicrob Agents Chemother1987;31:535–8.
23.
US Department of Health and Human Services. Antibiotic resistant strains of Neisseria gonorrhoeae. MMWR1987;36:No 5S, 1S–18S.
24.
RajakumarMKNgeowYFKhorBSLimKF.Ofloxacin, a new quinolone for the treatment of gonorrhoea. Sex Transm Dis1988;15:25–6.
25.
TenovirFC.Deoxyribonucleic acid probes for infectious diseases. Clin Microbiol Rev1988;1:82–101.
26.
GranattoPAFranzMR. Evaluation of a prototype DNA probe test for the noncultural diagnosis of gonorrhoea. J Appl Microbiol1989;27:632–5.
27.
SharranRGGoldbergM.Continuing increase in infectious syphilis-United States. MMWR1988;37:35–8.
28.
YoungHMoyesAMcMillanARobertsonDHH.Survey for treponemal infection by a new enzyme immunoassay. Genitourin Med1989;65:72–8.
29.
AdlerMW.Diagnostic, treatment, and reporting criteria for non-specific genital infection in sexually transmitted disease clinics in England and Wales. 1. Diagnosis. Br J Vener Dis1978;54:422–7.
30.
AryaOPMallinsonHAndrewsBESillisM.Diagnosis of urethritis: Role of polymorphonuclear leukocyte counts in gram stained urethral smears. Sex Transm Dis1984;11:10–7.
31.
BowieWR.Comparison of gram stain and first voided urine sediment in the diagnosis of urethritis. Sex Transm Dis1978;5:39–42.
32.
SwartzSLKrausSJHermannKLStangelMDBrownWJAllenSD.Diagnosis and etiology of non-gonococcal urethritis. J Infect Dis1978;138:445–54.
33.
LandisSJStewartIOCherneskyMAValue of the gram stained smear in the management of men with urethritis. Sex Transm Dis1988;15:78–84.
34.
AumonierFJ.Some problems in microscopy encountered in clinics for sexually transmitted diseases. Br J Vener Dis1978;544:346–7.
35.
RobinsonD TaylorThomasBJ.The role of Chlamydia trachomatis in genital tract and associated disease. J Clin Pathol1980;33:205–33.
36.
AlaniMDDarougarSBurnsD McDThinRNDunnH.Isolation of Chlamydia trachomatis from the male urethra. Br J Vener Dis1977;53:88–92.
37.
ShahmaneshM.Characteristics of inflammatory cells in urethral smears from men with non-gonococcal urethritis. Genitourin Med1989;65:18–21.
38.
MundayPE.Persistent and recurrent non-gonococcal urethritis. In: RobinsonD Taylor, ed. Clinical problems in sexually transmitted diseases. Dordrecht: Martinus Nyhoff, 1985:15–36.
39.
CroftsJNMaskillWJHealeyDSGustID.Particle agglutination assay for HIV. Lancet1987;ii:797–8.
40.
YoshidaTYamamotoN.Gelatin particle agglutination test for serum antibodies to HIV 1. Nippon Rinsho1988;45:1186–93.
41.
Communicable Diseases Surveillance Centre and Communicable Diseases (Scotland) Unit. AIDS Update. Br Med J1989;298:1057.
42.
DarbySCRizzaCRDollRSpoonerRJDStrattonIMThakarB.Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: Report on behalf of the directors of haemophiliac centres in the United Kingdom. Br Med J1989;298:1064–8.
43.
Department of Health. Statistical bulletin on sexually transmitted diseases. 1989.
44.
RizzaGTittiFRossiGBVeraniPMenniti-IppolitoFOlivaC.Sex as a risk factor for HTLV1 spread among intravenous drug abusers. Lancet1988;i:713.
45.
RichmanDD.The treatment of HIV infection. AIDS1988;2(Suppl 1): S137–S1442.
46.
MeriganTCSkowronGBozzetteSACirculating p24 antigen levels and responses to dideoxycitidine in human immunodeficiency virus (HIV) infections. Ann Intern Med1989;110:189–94.
47.
MeriganTC.Human interferon as a therapeutic agent. N Engl J Med1988;318:1458–60.
48.
FauciAS.Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. Ann Intern Med1989;110:373–85.